Martingale Asset Management L P raised its stake in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 181.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,744 shares of the company's stock after acquiring an additional 61,744 shares during the period. Martingale Asset Management L P owned approximately 0.19% of Nu Skin Enterprises worth $660,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Meeder Asset Management Inc. acquired a new position in Nu Skin Enterprises in the fourth quarter valued at about $25,000. US Bancorp DE raised its position in shares of Nu Skin Enterprises by 424.2% in the 4th quarter. US Bancorp DE now owns 7,460 shares of the company's stock valued at $51,000 after buying an additional 6,037 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Nu Skin Enterprises by 536.8% during the 4th quarter. Signaturefd LLC now owns 8,087 shares of the company's stock worth $56,000 after acquiring an additional 6,817 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of Nu Skin Enterprises by 2,412.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock worth $57,000 after acquiring an additional 7,888 shares in the last quarter. Finally, Bank of Montreal Can acquired a new stake in shares of Nu Skin Enterprises during the 4th quarter worth approximately $80,000. 82.84% of the stock is currently owned by institutional investors.
Nu Skin Enterprises Price Performance
Nu Skin Enterprises stock traded down $0.12 during mid-day trading on Friday, reaching $5.50. The company had a trading volume of 746,709 shares, compared to its average volume of 834,189. The business has a fifty day simple moving average of $7.22 and a 200 day simple moving average of $6.99. The company has a market cap of $273.23 million, a P/E ratio of -1.86 and a beta of 1.10. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.35 and a fifty-two week high of $14.00.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The business had revenue of $445.55 million for the quarter, compared to analyst estimates of $441.10 million. On average, equities research analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current year.
Nu Skin Enterprises Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were given a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 4.37%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises's dividend payout ratio (DPR) is currently -8.14%.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. StockNews.com cut Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Tuesday, April 8th. DA Davidson reduced their price objective on Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating on the stock in a research note on Friday, December 20th.
Read Our Latest Stock Analysis on Nu Skin Enterprises
About Nu Skin Enterprises
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
